.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers have recently identified ZFP91 as a critical ZFP91 myeloid leukemia regulator that drives EVI1 expression. Historically, clinicians linked EVI1 overexpression primarily to 3q26 chromosomal rearrangements. However, this study reveals how EVI1 levels remain high in many patients even without these specific genetic abnormalities. Consequently, these findings offer a fresh biological explanation for the poor clinical outcomes observed in a broader range of myeloid leukemia cases.
Ecotropic viral integration site 1 (EVI1) is a transcription factor that maintains hematopoietic stem cell function. Unfortunately, it becomes highly oncogenic when overexpressed in myeloid cells. While chromosomal rearrangements typically cause this elevation, many leukemia cases display high EVI1 levels despite possessing a normal 3q26 locus. To solve this clinical mystery, researchers utilized genome-wide CRISPR screening. They successfully discovered that zinc finger protein 91 (ZFP91) acts as the primary activator of EVI1 in these contexts.
Mechanistically, ZFP91 binds directly to the EVI1 promoter region. This binding actively enhances crucial histone modifications, specifically H3K4me3 and H3K27ac. Additionally, it significantly increases chromatin accessibility, which facilitates aggressive gene transcription. Furthermore, the study demonstrated that knocking out ZFP91 effectively reduced leukemia cell proliferation and EVI1 expression levels. Therefore, the ZFP91-EVI1 axis represents a promising new therapeutic target for patients facing EVI1-positive myeloid malignancies.
EVI1 is essential for maintaining hematopoietic stem cells, but its aberrant overexpression is a major indicator of poor prognosis and therapy resistance in myeloid leukemia.
ZFP91 acts as a transcriptional activator that binds to the EVI1 promoter, enhancing active chromatin marks like H3K4me3 and H3K27ac to drive gene expression.
The identification of the ZFP91-EVI1 axis suggests that ZFP91 could be a target for future therapies, especially for patients who overexpress EVI1 without traditional chromosomal rearrangements.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Hayashida H et al. Genome-wide screening identifies ZFP91 as a key regulator of EVI1 in myeloid leukemia. Oncogene. 2026 Apr 25. doi: 10.1038/s41388-026-03727-7. PMID: 42034869.
Unoki M et al. Identification of a novel human gene, ZFP91, involved in acute myelogenous leukemia. Int J Oncol. 2003 Jun;22(6):1213-9. PMID: 12738987.
Glass C et al. Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia. PLoS ONE. 2013;8(6):e67134. doi: 10.1371/journal.pone.0067134.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Researchers identify ZFP91 as a master regulator of EVI1 expression in myeloid leukemia, explaining high EVI1 levels in cases without 3q26 abnormalities....
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
